# Datesets

This folder contains freely available datasets that than can be used
for survival analysis.

| Dataset | Description | Samples | Features | Events | Outcome |
| ------- | ----------- | ------- | -------- | ------ | ------- |
| actg320_aids or actg320_death | [AIDS study][Hosmer2008] | 1,151 | 11 | 96 (8.3%) | AIDS defining event or death |
| breast-cancer | [Breast cancer][Desmedt2007] | 198 | 80 | 51 (25.8%) | Distant metastases |
| flchain | [Assay of serum free light chain][Dispenzieri2012] | 7874 | 9 | 2169 (27.5%) | Death |
| GBSG2 | [German Breast Cancer Study Group 2][Schumacher1994] | 686 | 8 | 299 (43.6%) | Recurrence free survival |
| veteran | [Veteran's Lung Cancer][Kalbfleisch2008] | 137 | 6 | 128 (93.4%) | Death |
| whas500 | [Worcester Heart Attack Study][Hosmer2008] | 500 | 14 | 215 (43.0%) | Death|

[Desmedt2007]: http://dx.doi.org/10.1158/1078-0432.CCR-06-2765 "Desmedt, C., Piette, F., Loi et al.: Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series. Clin. Cancer Res. 13(11), 3207–14 (2007)"

[Dispenzieri2012]: https://doi.org/10.1016/j.mayocp.2012.03.009 "Dispenzieri, A., Katzmann, J., Kyle, R., Larson, D., Therneau, T., Colby, C., Clark, R., Mead, G., Kumar, S., Melton III, LJ. and Rajkumar, SV. Use of monclonal serum immunoglobulin free light chains to predict overall survival in the general population, Mayo Clinic Proceedings 87:512-523. (2012)"

[Hosmer2008]: http://www.wiley.com/WileyCDA/WileyTitle/productCd-0471754994.html "Hosmer, D., Lemeshow, S., May, S.: Applied Survival Analysis: Regression Modeling of Time to Event Data. John Wiley & Sons, Inc. (2008)"

[Kalbfleisch2008]: http://www.wiley.com/WileyCDA/WileyTitle/productCd-047136357X.html "Kalbfleisch, J.D., Prentice, R.L.: The Statistical Analysis of Failure Time Data. John Wiley & Sons, Inc. (2002)"

[Schumacher1994]: http://ascopubs.org/doi/abs/10.1200/jco.1994.12.10.2086 "Schumacher, M., Basert, G., Bojar, H., et al. Randomized 2 × 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients. Journal of Clinical Oncology 12, 2086–2093. (1994)"
